Codiak BioSciences CDAK
$ 0.06
-55.98%
Quarterly report 2022-Q3
added 11-03-2022
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Douglas Edward Williams |
Employees in the company |
101 |
Shares |
21.8 M |
Market Cap[1] |
$ 2.15 M |
EBITDA (LTM) |
$ -62.7 M |
P/E (LTM) |
-0.18 |
P/S (LTM) |
1.34 |
EPS (LTM) |
-3.09 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.